by The rate is low and experts remind that the risk of secondary cancers is higher with standard chemotherapy
The US Food and Drug Administration (FDA) has been investigating 22 cases of T cell cancer that occurred after treatment with CAR-T, as revealed this Wednesday by two senior FDA officials, days…
Report a bug
